Anixa Biosciences, Inc.ANIXNASDAQ
Loading
SG&A Expenses Over TimeStable
Percentile Rank60
3Y CAGR+0.6%
5Y CAGR-2.0%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+0.6%/yr
vs +2.7%/yr prior
5Y CAGR
-2.0%/yr
Consistent
Acceleration
-2.0pp
Decelerating
Percentile
P60
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
2 yr
Consecutive declineStable
PeriodValueYoY Change
TTM$6.41M-3.3%
2025$6.63M-10.8%
2024$7.43M+18.2%
2023$6.29M-12.3%
2022$7.17M+1.4%
2021$7.07M+28.4%
2020$5.51M-2.8%
2019$5.66M-18.1%
2018$6.91M+56.7%
2017$4.41M-